Plantar fasciitis. Plantar fascial fibromatosis
Conditions
Interventions
Intervention 1: Intervention group 1: Patients will be treated with ESWT of the plantar fascia and the trigger points of the cuff muscles. ESWT treatment will be performed using a STORZ Medical MASTER
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Pain severity: Baseline pain intensity = 4 on a Visual Analog Scale (VAS) 0-10 Duration of symptoms: Presence of symptoms of plantar fasciitis for at least 6 weeks. Clinical diagnosis: Patients with plantar fasciitis and have tender points in the gastrocnemius-soleus muscles on the same side of the affected area, and this issue is clinically assessed and diagnosed by a physical medicine and rehabilitation specialist. No previous treatment or failure of conservative treatment: The patient must not have previously received any medical treatment for this disease or previous conservative treatments (NSAIDs or other analgesics, exercise programs and shoe inserts) have not been effective. Commitment to not taking anti-inflammatory drugs: Acceptance of not taking anti-inflammatory drugs during the treatment period. General health: No known acute or chronic inflammatory diseases or taking medications that interfere with the effects of treatment, including NSAIDs for other reasons Informed consent to participate in the study. Education level: Having sufficient education to understand the treatment methods and interventions performed and the ability to complete the assessment forms in this study
Exclusion criteria
Exclusion criteria: Malignancy (cancer) Active infections History of systemic inflammatory diseases or disseminated inflammatory rheumatic diseases Trauma Open wounds or injuries in the legs Neuropathy (nerve disorders) Radiculopathy (pressure on the spinal nerves) Peripheral vascular disorders (circulation problems in the limbs) Coagulation disorders (blood clotting problems) Use of anticoagulant drugs (due to increased risk of bleeding) Arthropathy (joint disease) Congenital or acquired deformities in the lower extremities Sequelae of previous fractures in the lower extremities Presence of metal prostheses or implants (including screws, pacemakers or internal fixators) in the treatment area Inability to understand the treatment or cognitive impairment if the person is unable to understand the treatment or complete the relevant assessment forms Previous treatment history including ESWT, injections in the area (corticosteroids, Platelet-rich plasma (PRP), prolotherapy) Not willing to participate in the study Contraindications to ESWT and dry needling, such as metal allergies, pregnancy, bleeding disorders Severe mental disorder including conditions that may impair the ability to provide informed consent or adhere to treatment protocols
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient's pain intensity with Visual Analogue Scale. Timepoint: In 3 sessions, before the start of the intervention, one month and three months after completing the three intervention sessions. Method of measurement: Completion of the Visual Analogue Scale by the patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ankle function assessment based on Foot function index (FFI). Timepoint: In 3 sessions, before the start of the intervention, one month and three months after completing the three intervention sessions. Method of measurement: Completion of the Foot Function Index (FFI) questionnaire by the patient.;Response to treatment and satisfaction with patient treatment based on the Roles and Maudsley Scale (RMS). Timepoint: In 3 sessions, before the start of the intervention, one month and three months after completing the three intervention sessions. Method of measurement: The patient describes their condition after treatment, and the doctor, based on these descriptions and clinical assessment, selects one of the four levels of the Roles and Maudsley Scale (RMS) and assigns the patient a score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Rajabi
Iran University of Medical Sciences
Outcome results
None listed